(Q43751860)

26 November 2017

Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors (English)

1 reference

26 November 2017

0 references

0 references

A Christopoulos

1

1 reference

PubMed ID

11578621

26 November 2017

K Wilson

series ordinal

2

1 reference

PubMed ID

11578621

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

26 November 2017

915

1 reference

26 November 2017

1

1 reference

26 November 2017

70-78

1 reference

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Muscarinic receptors--characterization, coupling and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Qualitative and quantitative assessment of relative agonist efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brainstem transected cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Cannabinoid receptors and their endogenous agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Role of cannabinoid receptors in memory storage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Cannabinoids, hippocampal function and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Cholinergic neurotransmission and synaptic plasticity concerning memory processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Inhibition of antagonist and agonist binding to the human brain muscarinic receptor by arachidonic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Anandamides inhibit binding to the muscarinic acetylcholine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Elevated endogenous cannabinoids in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Endogenous cannabinoid signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Muscarinic receptors involved in hippocampal plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

Anandamide – the other side of the coin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902825-6

10.1016/S0006-8993(01)02825-6

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11578621